Antenatal Corticosteroids in Preterm Pregnancies Complicated by Diabetes: A Review and Clinical Commentary
American Journal of Perinatology · 2026-06 · 43 (08) · 1098-1103
DOI: 10.1055/a-2852-4997 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Perinatology, online erschienen am 24.04.2026. Verfasst von Arielle Higgs und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Maternal Fetal Medicine, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Maryland School of Medicine, Balti…. Hauptthemen laut MEDLINE: Pregnancy in Diabetics, Adrenal Cortex Hormones, Diabetes, Gestational, Respiratory Distress Syndrome, Newborn.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Objective
This study aimed to review the biologic mechanisms, clinical evidence, and therapeutic considerations surrounding antenatal corticosteroid (ACS) use in preterm pregnancies complicated by gestational and pregestational diabetes, with a particular focus on the late preterm period and associated neonatal outcomes. Study Design Narrative review of randomized trials, observational studies, and mechanistic investigations evaluating fetal lung development, ACS exposure, and neonatal respiratory outcomes in diabetic pregnancies.
Results
Diabetes disrupts fetal lung maturation through fetal hyperinsulinemia and delayed surfactant synthesis, resulting in increased neonatal respiratory morbidity extending into the late preterm period. While late preterm ACS reduce the need for neonatal respiratory support, including transient tachypnea of the newborn, in non-diabetic populations, pregestational diabetic pregnancies were excluded from pivotal trials. Emerging observational and randomized data suggest similar respiratory benefit in diabetic pregnancies, though accompanied by predictable metabolic effects, including maternal hyperglycemia, which are modifiable with anticipatory clinical management.
Conclusion
Available biologic and clinical evidence supports consideration of late preterm ACS in pregnancies complicated by diabetes when delivery is anticipated within 7 days. With proactive metabolic management, respiratory benefits can be achieved while minimizing maternal and neonatal risks. Key Points Diabetes delays fetal lung maturation. Late preterm respiratory risk remains high. Antenatal corticosteroids (ACS) may reduce respiratory morbidity. Metabolic effects are predictable and modifiable. Individualized care optimizes outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Maternal Fetal Medicine, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Maryland School of Medicine, Baltimore, Maryland, United States.
ORCID-Profile: Arielle Higgs
Zitieren
APA
Higgs, A., Meeks, K., Reece, E. A., & Seif, K. E. (2026). Antenatal Corticosteroids in Preterm Pregnancies Complicated by Diabetes: A Review and Clinical Commentary. American Journal of Perinatology, 43(08), 1098-1103. https://doi.org/10.1055/a-2852-4997
Vancouver
Higgs A, Meeks K, Reece EA, Seif KE. Antenatal Corticosteroids in Preterm Pregnancies Complicated by Diabetes: A Review and Clinical Commentary. American Journal of Perinatology. 2026;43(08):1098-1103. doi:10.1055/a-2852-4997
BibTeX
@article{Higgs2026,
author = {Higgs, Arielle and Meeks, Kasey and Reece, E Albert and Seif, Karl E},
title = {Antenatal Corticosteroids in Preterm Pregnancies Complicated by Diabetes: A Review and Clinical Commentary},
journal = {American Journal of Perinatology},
year = {2026},
volume = {43},
number = {08},
pages = {1098--1103},
doi = {10.1055/a-2852-4997}
}
EUVIMED